The long term goal of this project is to minimize organ rejection and immunosuppressant toxicity, in each child with liver transplantation (LTx). Pre-LTx lymphocyte depletion permits steroid avoidance and lowers need for Tacrolimus immunosuppression. If underlying mechanisms were better understood, they could be used to reduce further, primary rejection (50%) and recurrent rejection during drug minimization (30%) on this protocol. Preliminary work leads us to hypothesize that donor-specific hyporeactivity and regulatorysuppressive effect are achieved at highly variable intervals among pediatric LTx with early rejection after steroid-free lymphocyte-depleting immunosuppression. We further hypothesize that this variability in immune-modulation is associated with patterns of single nucleotide polymorphisms (SNP) in extended MHCregion genes subserving proliferation, apoptosis, memory and B-cell-dependent functions. A clinical trial at our center will administer steroid-free Tacrolimus after depletion with 5 mg/kg rabbit anti-human-thymocyte globulin (rATG) to 80 children with LTx. The proposed mechanistic addendum study will entail serial peripheral blood samples from all children before and at 1, 3, and 12 months post-LTx.
Specific aims are 1. Longitudinal characterization of donor-specific alloreactivity, T-reg/suppressor cells (CD4+CD25+, CD8+28-), and anti-HLA alto-antibodies in each child, 2. Pre-LTx characterization of 29 SNPs distributed among 14 MHC genes, whose preliminary distribution patterns differ significantly between rejectors (biopsy-proven rejection at 60 days post-LTx), and non-rejectors. This will be done in 80 children and their biologic parents. SNPs showing > or < 50% expected transmission from parents to rejectors and whose transmission differs significantly between rejectors and non-rejectors, will be used to identify candidate loci with the transmission disequilibrium test, and 3. Validate potential candidate genes/loci within outcome groups, by a) measuring donor-specific proliferative/apoptotic/memory responses in T- and B-cell subsets by CFSE-MLR, b) whole genome mRNA expression to complement SNP associations, and minimize false-positives, and c) locusspecific gene expression (mRNA) for candidate loci c). If successful, future application of study results could improve pre-LTx drug selection, e.g., allocating steroids if SNP patterns predict rejection. Also, post-LTx drug minimization could be made safer, e.g., when T-reg/T-sup appear. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI073895-01
Application #
7251717
Study Section
Special Emphasis Panel (ZAI1-MP-I (S5))
Program Officer
Bridges, Nancy D
Project Start
2006-09-30
Project End
2010-08-31
Budget Start
2006-09-30
Budget End
2007-08-31
Support Year
1
Fiscal Year
2006
Total Cost
$372,108
Indirect Cost
Name
Children's Hosp Pittsburgh/Upmc Health Sys
Department
Type
DUNS #
044304145
City
Pittsburgh
State
PA
Country
United States
Zip Code
15224
Ashokkumar, Chethan; Soltys, Kyle; Mazariegos, George et al. (2017) Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children. Transplantation 101:131-140
Ningappa, M; Ashokkumar, C; Higgs, B W et al. (2016) Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection. Am J Transplant 16:497-508
Sindhi, Rakesh; Ashokkumar, Chethan; Higgs, Brandon W et al. (2016) Profile of the Pleximmune blood test for transplant rejection risk prediction. Expert Rev Mol Diagn 16:387-93
Ashokkumar, Chethan; Sun, Qing; Ningappa, Mylarappa et al. (2015) Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes. Transplantation 99:164-70
Sindhi, Rakesh; Ashokkumar, Chethan; Higgs, Brandon W (2011) Cellular alloresponses for rejection-risk assessment after pediatric transplantation. Curr Opin Organ Transplant 16:515-21
Ashokkumar, C; Talukdar, A; Sun, Q et al. (2009) Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 9:179-91
Ashokkumar, Chethan; Sun, Qing; Gupta, Ankit et al. (2009) Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free liver transplantation. Liver Transpl 15:978-85
Gupta, Ankit; Kumar, Chethan Ashok; Ningappa, Mylarappa et al. (2009) Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin. Transplantation 88:589-94
Talukdar, Anjan; AshokKumar, Chethan; Farrar, Jennifer et al. (2008) Lymphocyte subset reconstitution in pediatric liver recipients induced with steroid-free rabbit anti-human thymocyte globulin. Pediatr Transplant 12:804-8
Sindhi, Rakesh; Higgs, Brandon W; Weeks, Daniel E et al. (2008) Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection. Gastroenterology 135:830-9, 839.e1-10